Abstract
The t(7;12)(q36;p13) is a recurrent abnormality in acute myeloid leukemia (AML) of childhood. The involved gene on chromosome 12 is TEL; the 7q36 partner gene has not been identified. We describe morphologic, molecular and cytogenetic characterization of two cases of 7q36/12p13-associated AML that provide important insights regarding the consequences of this rearrangement. First, the molecular organization of the breakpoint regions differ significantly: one case is a reciprocal 7;12 translocation (RTR); the other has an insertion of 7q into 12p (INS). While 12p13 breakpoints in both patients interrupt TEL intron 1, the centromere to telomere orientation of the 7q36 sequences relative to the TEL sequences are inverted in INS compared to RTR. This difference makes it difficult to postulate a mechanism whereby both patients could produce a common fusion transcript. Further, no evidence was obtained for any TEL-containing fusion transcripts. Finally, we report the first cloning of a 7;12 genomic breakpoint (from RTR) and find that it maps to a site 30 kbp proximal to the HLXB9 gene in 7q36. Together, these data suggest that, unlike most leukemia-associated chromosomal rearrangements, the important consequence of the t(7;12) is likely not the generation of a novel fusion transcript, but instead the inactivation of TEL and/or a gene at 7q36.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Slater RM, von Drunen E, Kroes WG, Weghuis DO, van den Berg E, Smit EM, van der Does-van den Berg A, van Wering E, Hahlen K, Carroll AJ, Raimondi SC, Beverloo HB . t(7;12)(q36;p13) and t(7;12)(q32;p13) – translocations involving ETV6 in children 18 months of age or younger with myeloid disorders Leukemia 2001 15: 915–920
Tosi S, Harbott J, Teigler-Schlegel A, Haas OA, Pirc-Danoewinata H, Harrison CJ, Biondi A, Cazzaniga G, Kempski H, Scherer SW, Kearney L . t(7;12)(q36;p13), a new recurrent translocation involving ETV6 in infant leukemia Genes Chromos Cancer 2000 29: 325–332
Wlodarska I, La Starza R, Baens M, Dierlamm J, Uyttebroeck A, Selleslag D, Francine A, Mecucci C, Hagemeijer A, Van den Berghe H, Marynen P . Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies Blood 1998 91: 1399–1406
Satake N, Maseki N, Nishiyama M, Kobayashi H, Sakurai M, Inaba H, Katano N, Horikoshi Y, Eguchi H, Miyake M, Seto M, Kaneko Y . Chromosome abnormalities and MLL rearrangements in acute myeloid leukemia of infants Leukemia 1999 13: 1013–1017
Beverloo HB, Panagopoulos I, Isaksson M, van Wering E, van Drunen E, de Klein A, Johansson B, Slater R . Fusion of the homeobox gene HLXB9 and the ETV6 gene in infant acute myeloid leukemias with the t(7;12)(q36;p13) Cancer Res 2001 61: 5374–5377
Chakrabarti SR, Nucifora G . The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A Biochem Biophys Res Commun 1999 264: 871–877
Lopez RG, Carron C, Oury C, Gardellin P, Bernard O, Ghysdael J . TEL is a sequence-specific transcriptional repressor J Biol Chem 1999 274: 30132–30138
Fenrick R, Wang L, Nip J, Amann JM, Rooney RJ, Walker-Daniels J, Crawford HC, Hulboy DL, Kinch MS, Matrisian LM, Hiebert SW . TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1 Mol Cell Biol 2000 20: 5828–5839
Wang LC, Kuo F, Fujiwara Y, Gilliland DG, Golub TR, Orkin SH . Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL Embo J 1997 16: 4374–4383
Wang LC, Swat W, Fujiwara Y, Davidson L, Visvader J, Kuo F, Alt FW, Gilliland DG, Golub TR, Orkin SH . The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow Genes Dev 1998 12: 2392–2402
Golub TR, Barker GF, Lovett M, Gilliland DG . Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation Cell 1994 77: 307–316
Odero MD, Carlson K, Calasanz MJ, Lahortiga I, Chinwalla V, Rowley JD . Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping Genes Chromos Cancer 2001 31: 134–142
Rowley JD . The role of chromosome translocations in leukemogenesis Semin Hematol 1999 36 (Suppl. 7): 59–72
Golub TR, Barker GF, Stegmaier K, Gilliland DG . Involvement of the TEL gene in hematologic malignancy by diverse molecular genetic mechanisms Curr Top Microbiol Immunol 1996 211: 279–288
Golub TR, Barker GF, Stegmaier K, Gilliland DG . The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms Curr Top Microbiol Immunol 1997 220: 67–79
Kuno Y, Abe A, Emi N, Iida M, Yokozawa T, Towatari M, Tanimoto M, Saito H . Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12) Blood 2001 97: 1050–1055
Lacronique V, Boureux A, Valle VD, Poirel H, Quang CT, Mauchauffe M, Berthou C, Lessard M, Berger R, Ghysdael J, Bernard OA . A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia Science 1997 278: 1309–1312
Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM . The novel activation of ABL by fusion to an ets-related gene, TEL Cancer Res 1995 55: 34–38
Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den Berghe H, Marynen P . Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia Blood 1997 90: 2535–2540
Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS, Peeters P, Van Rompaey L, Van Etten RA, Ilaria R Jr, Marynen P, Gilliland DG . Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes EMBO J 1998 17: 5321–5333
Yagasaki F, Wakao D, Yokoyama Y, Uchida Y, Murohashi I, Kayano H, Taniwaki M, Matsuda A, Bessho M . Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation Cancer Res 2001 61: 8371–8374
Suto Y, Sato Y, Smith SD, Rowley JD, Bohlander SK . A t(6;12)(q23;p13) results in the fusion of ETV6 to a novel gene, STL, in a B-cell ALL cell line Genes Chromos Cancer 1997 18: 254–268
Yagasaki F, Jinnai I, Yoshida S, Yokoyama Y, Matsuda A, Kusumoto S, Kobayashi H, Terasaki H, Ohyashiki K, Asou N, Murohashi I, Bessho M, Hirashima K . Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5;12)(q31;p13) Genes Chromos Cancer 1999 26: 192–202
Cools J, Mentens N, Odero MD, Peeters P, Wlodarska I, Delforge M, Hagemeijer A, Marynen P . Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13) Blood 2002 99: 1776–1784
ISCN. An International System for Human Cytogenetic Nomenclature S Karger: Basel: 1995
Fink JM, Dobyns WB, Guerrini R, Hirsch BA . Identification of a duplication of Xq28 associated with bilateral periventricular nodular heterotopia Am J Hum Genet 1997 61: 379–387
World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues IARC Press: Lyon 2001
Nucifora G . The EVI1 gene in myeloid leukemia Leukemia 1997 11: 2022–2031
Peeters P, Wlodarska I, Baens M, Criel A, Selleslag D, Hagemeijer A, Van den Berghe H, Marynen P . Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders Cancer Res 1997 57: 564–569
Pekarsky Y, Rynditch A, Wieser R, Fonatsch C, Gardiner K . Activation of a novel gene in 3q21 and identification of intergenic fusion transcripts with ecotropic viral insertion site I in leukemia Cancer Res 1997 57: 3914–3919
Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA . Tumour predisposition in mice heterozygous for a targeted mutation in Nf1 Nat Genet 1994 7: 353–361
Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ . The murine gene p27Kip1 is haploinsufficient for tumour suppression Nature 1998 396: 177–180
Venkatachalam S, Shi YP, Jones SN, Vogel H, Bradley A, Pinkel D, Donehower LA . Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation EMBO J 1998 17: 4657–4667
Shannon KM, Le Beau MM, Largaespada DA, Killeen N . Modeling myeloid leukemia tumor suppressor gene inactivation in the mouse Semin Cancer Biol 2001 11: 191–200
Chomczynski P, Sacchi N . Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 1987 162: 156–159
Acknowledgements
The authors would like to acknowledge the contribution of Dr Scott Benson to the early stages of this work and the Department of Pediatrics, Divisions of Hematology/Oncology and Blood and Marrow Transplantation at the University of Minnesota for providing clinical information. This work was supported by a grant from the Leukemia Research Fund (to BH and KFC).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simmons, H., Oseth, L., Nguyen, P. et al. Cytogenetic and molecular heterogeneity of 7q36/12p13 rearrangements in childhood AML. Leukemia 16, 2408–2416 (2002). https://doi.org/10.1038/sj.leu.2402773
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402773
Keywords
This article is cited by
-
Engineered model of t(7;12)(q36;p13) AML recapitulates patient-specific features and gene expression profiles
Oncogenesis (2022)
-
Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects
Biomarker Research (2015)
-
Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination
Nature Immunology (2010)
-
Genetic alterations in children and adolescents with acute myeloid leukaemia
Clinical and Translational Oncology (2010)
-
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Leukemia (2004)